Virazole / Ribavirin

Modified on 2009/10/14 21:48 by admin
Ribavirin, sold under the brand name Virazole, is an antiviral indicated for the treatment of severe respiratory tract infections in hospitalized infants and young children. Ribavirin is administered by oral inhalation (breathing in the medicine in mist form through the mouth). Approved by the U.S. Food and Drug Administration in 1985, Ribavirin is made by ICN Pharmaceuticals.

Potential side effects of Ribavirin include, but may not be limited to, headache, itching, redness, skin rash or irritation. Ribavirin has been linked to decreased respiratory function in infants. In 2003, several former SARS patients treated with Ribavirin and steroids developed a bone degeneration disorder known as avascular necrosis. Avascular necrosis results from the temporary or permanent loss of the blood supply to the bones. Without blood, the bone tissue dies and causes the bone to collapse.

See your doctor if you have experienced serious side effects associated with Ribavirin. In addition, it may be important to contact an attorney who can help you protect your legal rights. Please keep in mind that there may be time limits within which you must commence suit.

See Also

  1. Respiratory Syncytial Virus or RSV Drugs: Overview
  2. Bone, Joint & Muscle Disorders: Overview
  3. Headaches
  4. Lung & Airway Disorders
  5. Skin Disorders: Overview
  Name Size